(Q34581923)

3 August 2017

title

Optical imaging predicts tumor response to anti-EGFR therapy (English)

1 reference

3 August 2017

1 reference

Emily E Helman

1

1 reference

3 August 2017

J Robert Newman

2

1 reference

3 August 2017

Nichole R Dean

3

1 reference

3 August 2017

Wenyue Zhang

4

1 reference

3 August 2017

Kurt R Zinn

5

1 reference

3 August 2017

Eben L Rosenthal

6

1 reference

3 August 2017

publication date

1 July 2010

1 reference

Cancer Biology and Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

10

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

166-171

1 reference

describes a project that uses

3 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3040897/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

The biology of epidermal growth factor receptor and its value as a prognostic/predictive factor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Epidermal growth factor receptor as a therapeutic target in head and neck cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Can cure be achieved in patients with head and neck carcinomas? The problem of second neoplasm

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

A comprehensive review of oral cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040897

Pain, function, and psychologic outcome before, during, and after intraoral tumor resection.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.2.12164

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.2.12164

Functional outcomes after treatment of squamous cell carcinoma of the base of the tongue

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20505368

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20505368

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/CBT.10.2.12164

1 reference

3 August 2017

1 reference

3 August 2017

1 reference